(Q38200704)

English

At the centennial of Michaelis and Menten, competing Michaelis-Menten steps explain effect of GLP-1 on blood-brain transfer and metabolism of glucose

scientific article published on 30 April 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

At the centennial of Michaelis and Menten, competing Michaelis-Menten steps explain effect of GLP-1 on blood-brain transfer and metabolism of glucose (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

author name string

Michael Gejl

1

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Jørgen Rungby

2

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Birgitte Brock

3

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

30 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Basic and Clinical Pharmacology and Toxicology

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

115

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

162-171

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Mechanisms linking obesity to insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Aggregation of vascular risk factors and risk of incident Alzheimer disease

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Intensive versus conventional glucose control in critically ill patients

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Identical mRNA for preproglucagon in pancreas and gut.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Neuroprotective properties of GLP-1: theoretical and practical applications

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Biology of incretins: GLP-1 and GIP

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Distribution of GLP-1 and PACAP receptors in human tissues

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

The glucagon-like peptide-1 receptor--or not?

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

The role of gut hormones in glucose homeostasis

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

New developments in the incretin concept

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Glucagon-like peptide 1(GLP-1) in biology and pathology

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

The Physiology of Glucagon-like Peptide 1

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Influence of GLP-1 on myocardial glucose metabolism in healthy men during normo- or hypoglycemia

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Incretin effects on β-cell function, replication, and mass: the human perspective

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

GLP-1 and extra-islet effects

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Is the GLP-1 system a viable therapeutic target for weight reduction?

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

How palatable food disrupts appetite regulation

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

On the physiology of GIP and GLP-1.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal system

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Incretin-based therapies: can we achieve glycemic control and cardioprotection?

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Physiology of GLP-1--lessons from glucoincretin receptor knockout mice

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

ROS and brain diseases: the good, the bad, and the ugly

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Vascular cognitive impairment, dementia, aging and energy demand. A vicious cycle

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Diabetes, obesity, and the brain

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Role of central nervous system glucagon-like Peptide-1 receptors in enteric glucose sensing

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Brain Function and Blood Flow / Niels A. Lassen, David H. Ingvar and Erik Skinhøj. - (10.1978)

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Radioactive oxygen-15 in the study of cerebral blood flow, blood volume, and oxygen metabolism

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Neurobarrier coupling in the brain: a partner of neurovascular and neurometabolic coupling?

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Cerebral glucose metabolism in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Facilitated transfer of glucose from blood into brain tissue

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Acute tryptophan depletion in rats alters the relationship between cerebral blood flow and glucose metabolism independent of central serotonin.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Updated energy budgets for neural computation in the neocortex and cerebellum

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Mitochondria and neuronal activity.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Sugar for the brain: the role of glucose in physiological and pathological brain function

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Effects of fluctuating glucose levels on neuronal cells in vitro

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Estimates of Michaelis-Menten constants for the two membranes of the brain endothelium.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Hyperglycemia in acute stroke

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Facilitated transport of glucose from blood to brain in man and the effect of moderate hypoglycaemia on cerebral glucose utilization

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Glucose variability; does it matter?

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Glucagon-like peptide-1 protects NSC-34 motor neurons against glucosamine through Epac-mediated glucose uptake enhancement

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

AMPK: a nutrient and energy sensor that maintains energy homeostasis

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Glucagon-like peptide-1 inhibits blood-brain glucose transfer in humans

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

An input function estimation method for FDG-PET human brain studies

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Noninvasive quantification of the cerebral metabolic rate for glucose using positron emission tomography, 18F-fluoro-2-deoxyglucose, the Patlak method, and an image-derived input function.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Human cerebral blood flow and metabolism in acute insulin-induced hypoglycemia

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

A (3H)2-Deoxyglucose Method for Comparing Rates of Glucose Metabolism and Insulin Responses Among Rat Tissues In Vivo: Validation of the Model and the Absence of an Insulin Effect on Brain

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Change in hexose distribution volume and fractional utilization of [18F]-2-deoxy-2-fluoro-D-glucose in brain during acute hypoglycemia in humans

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Insulin increases glucose transfer across the blood-brain barrier in man.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Effects of insulin on brain glucose metabolism in impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Insulin in the brain: there and back again

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders?

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Insulin and the brain

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Insulin signaling in the central nervous system: learning to survive

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance: the cerebral basis for impaired control of food intake in metabolic syndrome?

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Effects of acute and chronic hyperglycemia on the neurochemical profiles in the rat brain with streptozotocin-induced diabetes detected using in vivo ¹H MR spectroscopy at 9.4 T

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Brain imaging in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Effects of glucagon-like peptide 1 (7-36 amide) on whole-body protein metabolism in healthy man

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12240

21 January 2018

Identifiers

10.1111/BCPT.12240

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38200704&oldid=1746864259"